|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| C07K 7/06 | (2006.01) | ||
| C12N 5/0783 | (2010.01) |
| (11) | Number of the document | 3456339 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18201334.2 |
| Date of filing the European patent application | 2014-08-04 | |
| (97) | Date of publication of the European application | 2019-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-20 |
| (46) | Date of publication of the claims translation | 2021-12-10 |
| (30) | Number | Date | Country code |
| 201313987 | 2013-08-05 | GB | |
| 201361862213 P | 2013-08-05 | US | |
| 201403297 | 2014-02-25 | GB |
| (72) |
FRITSCHE, Jens , DE
SINGH, Harpreet , DE
SONG, Colette , DE
WALTER, Steffen , US
WEINSCHENK, Toni , DE
|
| (73) |
immatics biotechnologies GmbH ,
Paul-Ehrlich-Strasse 15, 72076 Tübingen,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nauja imunoterapija nuo kelių navikų, tokių kaip plaučių vėžys, įskaitant NLPV |
| NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC |
| Payment date | Validity (years) | Amount | |
| 2023-07-24 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-08-04 |